Nicox S.A. (EPA:ALCOX)

France · Delayed Price · Currency is EUR

0.3780

+0.0020 (0.53%)

Jun 3, 2026, 5:35 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Research and Development	16.77M	7.86M	6.90M	3.27M	7.23M
Pharmaceutical Research and Development Growth	113.41%	13.84%	111.04%	-54.78%	-43.96%
Total	16.77M	7.86M	6.90M	3.27M	7.23M
Total Growth	113.41%	13.84%	111.04%	-54.78%	-43.96%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Japan	16.22M	3.15M	-	-	-
Japan Growth	415.48%	-	-	-	-
China	236.67K	1.50M	-	-	-
China Growth	-84.22%	-	-	-	-
United States	308.71K	3.21M	-	-	-
United States Growth	-90.37%	-	-	-	-
Europe	3.00K	4.80K	-	-	-
Europe Growth	-37.50%	-	-	-	-
Total	16.77M	7.86M	-	-	-
Total Growth	113.41%	-	-	-	-

Source: S&P Global Market Intelligence.